Back to company

ABL BIOTEC A/S: Financial statements 2015

CVR: 50811018

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -122,431 and a net result of DKK 2,230,370 compared with DKK 3,774,071 the year before. Equity amounted to DKK 24,842,691. The solvency ratio was 99.5%.

Gross Profit
-122,431 kr.
Profit/Loss
2,230,370 kr.
Equity
24,842,691 kr.
Total Assets
24,969,295 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015--122 t.2.2 mio.24.8 mio.-
2014--100 t.3.8 mio.23.7 mio.-
2013--97 t.2.7 mio.22.4 mio.-
2012--51 t.3.7 mio.21.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

ABL BIOTEC A/S: The 2014 annual report is outMar 26, 2015

ABL BIOTEC A/S has published its annual report for 2014. Gross profit came to DKK -100,370, and the net result was DKK 3,774,071.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees. In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity amounted to DKK 27,884,586.